SC 13G

Company

CERO THERAPEUTICS HOLDINGS, INC.

Filed

February 8, 2022

Accession Number

0001193125-22-031001

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →